--- title: "National Microbiology Framework - Lot 2: Research and Development Goods and Services" ocid: "ocds-h6vhtk-02a9d6" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02a9d6" markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-02a9d6.md" json_url: "https://d3tenders.com/contract/ocds-h6vhtk-02a9d6.json" source: "Find A Tender Service" current_stage: "Award" buyer: "PUBLIC HEALTH ENGLAND" published: "2021-05-10" --- # National Microbiology Framework - Lot 2: Research and Development Goods and Services Buyer: PUBLIC HEALTH ENGLAND Current stage: Award OCID: ocds-h6vhtk-02a9d6 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02a9d6) [Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-02a9d6.json) ## Summary The procurement process involves Public Health England as the buying organisation, procuring services under the title "National Microbiology Framework - Lot 2: Research and Development Goods and Services." This tender falls within the medical equipment, pharmaceuticals, and personal care products industry category and is located in London, UK. The procurement stage is marked as complete, following an open procedure as the procurement method. The relevant contract was signed on 23 April 2021, with an estimated value of £1.5 billion, covering services primarily for research and development activities in the medical field, including the supply of diagnostic equipment and services. This tender presents substantial business opportunities, particularly for companies involved in research and development, medical diagnostics, and healthcare services. Small and medium-sized enterprises (SMEs) and larger firms offering innovative solutions in medical equipment, assay development, or managed equipment services would find themselves well-positioned to compete. With the framework set to adapt to new market developments, suppliers can propose updated or new goods and services that align with the evolving needs of healthcare authorities, making this a dynamic opportunity for growth in the healthcare sector. ## Notice Lot 2 is for the supply of goods and/or services for the qualitative/quantitative examination of specimens/samples and the development of assays/kits/medical or therapeutic products. This Lot consists of goods and services mainly for research and development, experimentation and study therefore CE marked (or UKCA marked) is not mandatory. This Lot includes provisions for reagent rental and managed equipment services. Please note that this Award Notice is for Lot 2, however the Framework Agreement encompasses the following four lots: - Lot 1: Diagnostic Goods and Services - Lot 2: Research and Development Goods and Services - Lot 3: Manufacturing, Product Development and Commercialisation - Lot 4: Clinical Laboratory Diagnostic Testing Services ### Lot Information Lot 1 The Framework Agreement relates to the supply of diagnostics Goods for the qualitative / quantitative examination of specimens / samples and the development or manufacturing of assays / kits / medication and related Services. It also relates to the supply of diagnostics Services for the qualitative / quantitative examination of specimens / samples or the development or manufacturing of assays / kits / medication. The framework also covers Clinical Laboratory Diagnostic Testing Services. The term of the framework will be for an initial 2 years with options to extend by up to a further 2 years. Additional information: The value attributed to each Lot is an approximate estimate only. As indicated in Section VI.3. of this Notice, the actual values will be to such level as those purchasing under the Framework Agreement consider necessary to provide suitable requirements. Options: The framework agreement will be for an initial period of 24 months with options exercisable by the Authority under the framework agreement to extend the duration in increments by up to a maximum of 24 months. Therefore, the total maximum duration of the framework agreement is 48 months. The Authority will also have the option to purchase new and/or updated Goods and/or Services which the Supplier proposes should be added to its range as described in Section VI.3 below. ## Key Details | Field | Value | | --- | --- | | Publication source | Find A Tender Service | | Latest notice | https://www.find-tender.service.gov.uk/Notice/010197-2021 | | Notice type | Tender Notice | | Procurement type | Framework | | Procurement category | Goods | | Procurement method | Open | | Procurement method details | Open procedure | | Tender suitability | Not specified | | Awardee scale | Large, SME | | All stages | Tender, Award | ## Dates | Field | Value | | --- | --- | | Publication date | 10 May 2021 | | Submission deadline | Not specified | | Future notice date | Not specified | | Award date | 22 Apr 2021 | | Contract period | Not specified | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | Not specified | | Lots value | Not specified | | Awards value | Not specified | | Contracts value | £1,500,000,000 | ## Status | Field | Value | | --- | --- | | Tender status | Complete | | Lots status | Cancelled | | Awards status | Active | | Contracts status | Active | ## Buyer | Field | Value | | --- | --- | | Main buyer | PUBLIC HEALTH ENGLAND | | Locality | LONDON | | Post town | North West London | | Postcode | NW9 5EQ | | Country | England | | ITL 1 | TLI London | | ITL 2 | TLI7 Outer London - West and North West | | ITL 3 | TLI71 Barnet | | Local authority | Barnet | | Electoral ward | Colindale South | | Westminster constituency | Hendon | | Delivery location | Not specified | ## Supplier | Field | Value | | --- | --- | | Number of suppliers | 69 | | Supplier names | A.MENARINI DIAGNOSTICS; ABBOTT RAPID DIAGNOSTICS; ABCAM; ACARRIER; AGENA BIOSCIENCE; APPLETON WOODS; AUSDIAGNOSTICS; BECTON, DICKINSON; BGI GENOMICS; BIO-RAD LABORATORIES; BIO-TECHNE; BIOCONNECTIONS; BIOSERV; BIOSPYDER TECHNOLOGIES; CAMBRIDGE BIOSCIENCE; CAMBRIDGE LIFE SCIENCES; CLENT LIFE SCIENCE; DON WHITLEY SCIENTIFIC; EUROFINS BIOMNIS; EUROIMMUN; EUROPLAZ TECHNOLOGIES; FISHER SCIENTIFIC; FUJIREBIO EUROPE; GENEFIRST; GLOBAL LIFE SCIENCES SOLUTIONS OPERATIONS; GREINER BIO-ONE; HAMILTON ROBOTICS; HEALTHLINKED; HOLOGIC; ILLUMINA CAMBRIDGE; IMMENSA HEALTH CLINIC; INTERTEK TESTING & CERTIFICATION; LGC GENOMICS; LIFE TECHNOLOGIES; LUMINEX; MALVERN MEDICAL DEVELOPMENTS; MGI INTERNATIONAL SALES; MICROBIAL GENOMICS LTD (TRADING AS MICROBESNG; MORNINGTON 2000LLP TRADING AS STERILAB SERVICES; NATURAL HISTORY MUSEUM TRADING; NEW ENGLAND BIOLABS; OXFORD BIOSYSTEMS; OXFORD IMMUNOTEC; OXFORD NANOPORE DIAGNOSTICS; PCR BIOSYSTEMS; PERKINELMER LAS (UK; PROMAKE; PROMEGA; QIAGEN; QUANTERIX; QUANTUMDX GROUP; RANDOX LABORATORIES; ROCHE DIAGNOSTICS; SARSTEDT; SCIENTIFIC LABORATORY SUPPLIES; SIEMENS HEALTHCARE DIAGNOSTICS; STRATECH SCIENTIFIC; SYSMEX; TECAN; TECHNO-PATH DISTRIBUTION; TEVA; THERMO ELECTRON MANUFACTURING LTD T/A THERMO FISHER SCIENTIFIC; THERMO FISHER DIAGNOSTICS; THERMOFISHER SCIENTIFIC T/A STERILIN; UNA HEALTH; V. H. BIO; VWR INTERNATIONAL; WOLF LABORATORIES; YOURGENE HEALTH | ## CPV Codes ### Divisions - 33 - Medical equipments, pharmaceuticals and personal care products ### Codes - 33000000 - Medical equipments, pharmaceuticals and personal care products ## Release History - 10 May 2021 at 21:55 - TenderUpdate - Tender Notice - https://www.find-tender.service.gov.uk/Notice/010197-2021 - 23 Apr 2021 at 21:55 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/008805-2021 ## Notice URLs - https://ted.europa.eu/udl?uri=TED:NOTICE:533940-2020:TEXT:EN:HTML - https://www.gov.uk/government/organisations/charity-commission - https://www.gov.uk/government/organisations/public-health-england - https://www.nhs.uk/servicedirectories/pages/nhstrustlisting.aspx ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-02a9d6. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-02a9d6.json.